---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-122815"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2021-10-05T23:59:59+00:00"
generated_at: "2026-06-28T22:49:05.964637+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Eloxx enters $30M loan agreement with Hercules; repays $6.7M prior loan

## Summary
- Term loans up to $30M: Tranche 1 $12.5M funded Sep 30, 2021; Tranche 2 $7.5M subject to clinical milestones (available until Aug 15, 2022); Tranche 3 $10M subject to lender discretion.
- Interest at greater of 9.50% or prime+6.25%; principal amortization begins April 2023, matures April 2025.
- Used $7.7M to prepay and terminate prior Silicon Valley Bank loan ($6.67M outstanding, plus prepayment premium and final charge).
- Loan secured by substantially all assets of Eloxx, Zikani Therapeutics (wholly owned), and Israeli subsidiary, excluding IP.
- Customary covenants limit additional debt, dividends, asset sales; prepayment premium of 3%–1% depending on timing.

## SEC filing metadata
- accession: 0001104659-21-122815
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2021-10-05T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465921122815/0001104659-21-122815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465921122815/tm2129268d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-122815
- JSON: https://secwatch.observer/filing/0001104659-21-122815.json
- Plain text: https://secwatch.observer/filing/0001104659-21-122815.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.